European Union: Solvency II Disclosures - The Dawn Of A New - And Transparent - Era

This year, the majority of insurers across the EU are releasing their first sets of public, audited Solvency II-basis results and disclosures ("SFCRs"). Insurers reporting on a solo basis released their SFCRs towards the end of May. Group disclosures must be released by the end of June, although some groups chose to release both group and solo results together.

This is a landmark event because, for the first time, and from now on, a comprehensive picture of the European insurance industry, firm by firm, is being provided using the Solvency II valuation and capital basis. This goes much further than the previous snapshot of the industry as a whole provided by EIOPA's December 2016 report on the long-term guarantee ("LTG") measures and measures on equity risk (the "LTG report").

This client briefing explains the information that is published in SFCRs and highlights some trends emerging from the SFCRs released so far. We plan to issue an updated analysis once individual group figures are available in full.

Solvency II public reporting – what has been disclosed?

The SFCR contains narrative disclosures on the insurer's business and performance, organisation and governance, risk management, risk profile, Solvency II valuation methodology and approach, capital resources ("own funds") and capital requirements. Where relevant, the SFCR explains the difference in capital requirement between the insurer's own model and the Solvency II standard formula.

The disclosures are supplemented by balance sheet and P&L data, the impact of the LTG and transitional measures, and information on any group undertakings.

The SFCR disclosures thus include:

  • The Solvency II balance sheet and valuation methodologies, judgements and assumptions, and differences from those used for the insurer's financial statements.
  • The effect on solvency of the matching adjustment, volatility adjustment and the transitional measures on the risk-free interest rate and technical provisions.
  • The insurer's own funds, capital management, restrictions on the use of capital, and the use of the transitional measures on own funds.
  • The insurer's SCR split by risk module or risk category (for internal models).
  • Where the SCR is calculated using an internal model, the scope and use of the model; methods used; the nature and appropriateness of data; and the main differences from the standard formula.
  • Risk exposures and concentrations across risk categories together with stress testing and sensitivity analysis.
  • Organisational, governance and (where applicable) group structures.

Long-term guarantee (LTG) and transitional measures

The LTG and transitional measures were introduced by the 2014 Omnibus II Directive, which provided for public disclosure of the impact of those measures. They have the following key effects:

  • The matching adjustment (MA) – in essence the liquidity premium that featured in the UK's former ICAS regime – is designed to avoid changes in asset spreads unduly affecting the own funds of insurers that hold bonds, along with other assets with similar cash flow characteristics to maturity, where the cash flows on those assets are matched to cash flows on the insurer's liabilities. The MA adjusts the risk-free interest rate term structure in line with the spread movement on the relevant assets. The MA primarily affects the valuation of technical provisions, and therefore the insurer's own funds.
  • The volatility adjustment (VA) is designed to avoid pro-cyclical investment behaviour by adjusting the risk-free interest rate term structure to mitigate the effect of exaggerated bond spreads. The VA is calculated by EIOPA based on reference portfolios of assets for relevant currencies. The VA primarily affects the valuation of technical provisions, and therefore the insurer's own funds. The VA and MA cannot be applied together.
  • The transitional measure on risk-free interest rates permits insurers to smooth the transition to the Solvency II risk-free interest rate term structure (including VA where applicable) linearly over 16 years. It cannot be applied where the MA is used.
  • The transitional measure on technical provisions permits insurers to spread the move to the Solvency II value of technical provisions (including the impact of the VA where applicable) linearly over 16 years.

The LTG and transitional measures therefore have a dual policy role in the Solvency II framework:

  • Recognising the long-term, often illiquid characteristics of insurance liabilities: the LTG measures seek to insulate insurers' long-term liabilities from short-term market volatility, and to align the discounting of liabilities with the return on backing assets where an insurer intends to hold these assets to maturity.
  • Financial stability: Adjustments to the discount rate smooth short-term balance sheet volatility and so are intended to dis-incentivise pro-cyclical investment behaviour. Transitional measures provide a phasing-in period for insurers to adjust to new levels of capital, recognising that insurers have substantial long-term back books that were not priced on a Solvency II basis.

What does the public reporting tell us so far?

        (I)    The MA and transitional measure on technical provisions are significant contributors to solvency in the UK industry.

As expected, the MA and transitional measure on technical provisions contributed significantly to the capitalisation of those insurers, mainly in the UK, with long-term, illiquid annuity business on balance sheet. For those organisations using the measures, the reported effect on technical provisions (in percentage terms) was broadly in the low single digits for either measure, with a consequential reported increase in eligible own funds in some cases exceeding 40%. This is broadly consistent with EIOPA's comment in its LTG report that:

"A slight relative increase of technical provisions may lead to a significant relative reduction of own funds, in particular for life insurance undertakings. For a typical life insurance undertaking the ratio of own funds and technical provisions is 1/10. Therefore, an increase of technical provisions of 1% would lead to a reduction of own funds of 10%." 1

        (II)    The impact of VA is much more limited for the UK industry.

For those insurers we reviewed, the VA had a much smaller (single digit percentage) impact on own funds. Given that the VA and MA cannot be applied together a more complete picture is likely to emerge as further group results become available. However, this initial observation is consistent with EIOPA's LTG report findings, which showed that the VA increased UK insurers' SCR solvency ratios from 141% to 147%, whereas the MA increased SCR solvency ratios from 73% to 140%.2

        (III)    Transitional relief for the risk margin contributes substantially to insurers' overall capital.

There has been much discussion of the effect of the risk margin in the UK industry in the last two years. Some insurers have disclosed that the risk margin, adjusted for the effect of the transitional measure on technical provisions, has been equivalent to, and in some cases in excess of, around 50% of the SCR. Since 2015, the PRA has said clearly and repeatedly that, while the concept of risk margin is sound, its design is leading to disproportionate and excessively interest rate-sensitive outcomes, which in turn are risking pro-cyclical effects.3

Implications for firms

As expected, the disclosures to date have confirmed the importance of the LTG and transitional measures to the UK life industry. This pattern reflects the significant volumes of life business with investment guarantees written in the UK, and is broadly comparable with the findings previously released by EIOPA in its LTG report.

The PRA has made clear its view that reliance on transitionals and on the LTG package generally is both appropriate and, because this is acceptable-quality capital, no bar in principle to the payment of dividends. Consequently, there remain good reasons to conclude that the UK industry is currently well-capitalised on the Solvency II basis. Indeed, EIOPA's LTG report highlights that "...feedback from National Supervisory Authorities indicates that there is no specific case yet, where undue capital relief was observed for an undertaking due to the application of the LTG measures or measures on equity risk." 5

That said, we would expect to see increasing levels of capital management activity in the life sector over the coming years and a continued review of strategic options and business models in this light. We expect this to be a strong supervisory focus for the PRA, as the transitional measure on technical provisions steadily amortises and eventually winds down towards 2032. In the shorter term, careful, on-going capital planning and liability management will clearly be needed to accommodate this amortisation and avoid any significant time mismatch with the run-off of liabilities.

Finally, against a background where the operation of the risk margin is incentivising firms to offshore longevity risk - a trend evidently, to judge from recent public statements, of increasing concern to the PRA6 - the SFCR disclosures underscore the case for a reform of the risk margin. We know from Sam Woods' recent evidence to the TSC, and as further stated by David Rule in his speech given at the ABI on 21 February 2017, that the PRA board has considered whether unilaterally to introduce such reform at a UK level, but concluded - apparently on fine balance - against doing so. If, however, the EIOPA/European Commission review process now underway does not lead to such reform on an acceptable timetable, the PRA may well conclude that balance has tilted.

Footnotes

1 LTG report section II.2

2 LTG report sections III.2 and III.3

3  For example, Sam Woods' written evidence to the Treasury Committee commented that: "Although the fundamental regime is sound, there are nevertheless adjustments that need to be made to address issues in important areas, with the most obvious being that the design of the Risk Margin is excessively volatile due to its sensitivity to risk-free interest rates." [Written evidence submitted by the Prudential Regulation Authority (SOL0051)]

4 For example, Sam Woods' speech on Insurance Supervision at the PRA to the London Business School on 20 March 2017

5 LTG report section II.3

6 For example, written evidence submitted to the Treasury Committee by the Prudential Regulation Authority (SOL0051)

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.

Disclaimer

Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.

Registration

Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.

Cookies

A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.

Links

This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.

Mail-A-Friend

If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.

Security

This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.